济民健康管理股份有限公司关于回购公司股份比例达2%暨回购进展公告

Group 1: Share Buyback Announcement - The company has approved a share buyback plan using its own funds and bank loans, with a maximum price of RMB 10 per share and a total amount between RMB 100 million and RMB 200 million, to be executed within 12 months [2] - As of February 27, 2026, the company has repurchased 10,626,840 shares, representing 2.02% of the total share capital, with a total expenditure of RMB 90,962,358.7, excluding transaction fees [3] - In February 2026 alone, the company repurchased 5,286,560 shares, accounting for 1.01% of the total share capital, with a total payment of RMB 48,876,806.4, excluding transaction fees [3] Group 2: Guarantee for Subsidiary Financing - The company has provided a guarantee for its wholly-owned subsidiary, Jumin Biotechnology Co., Ltd., for a loan application to a bank, with a maximum guarantee amount of RMB 55 million, which is 3.71% of the company's latest audited net assets [7][8] - The board of directors has approved a total guarantee limit of up to RMB 600 million for the subsidiary's financing needs, which includes various forms of guarantees [9] - The guarantee is deemed necessary to support the subsidiary's business expansion and financing needs, with minimal risk to the company [13]